CBD Myths

CBD is non-psychoactive

CBD is not an intoxicant, but it would be misleading to describe it as non-psychoactive. Though its effects are not nearly as innebriating as THC, CBD has powerful mood-altering properties and has a typically positive effect on the psyche.

CBD is sedating

CBD is not intrinsically sedating, though its anti-anxiety properties may help promote better sleep. There is evidence to suggest low-to-moderate doses of CBD mildly increase energy and alertness. Very high doses may prove sedative, especially if taken in combination with THC.

Hemp CBD, Cannabis CBD, and CBD Isolate are all the same

While research on the topic is relatively early, CBD is typically more effective when delivered alongside other cannabinoids and terpenes found naturally in the hemp and cannabis plants. Isolated or synthesized CBD can have limited therapeutic potential, specifically when higher doses are required.

CBD works by activating the Endocannabinoid system

THC directly binds to and activates our cannabinoid receptors, and evidence suggests it also triggers relief for pain, spasticity, and nausea. Due to the intoxicating side effects, however, the use of products containing THC requires regulation. Other cannabinoids such as CBD were believed to function similarly, but CBD increases cannabinoid signaling indirectly, slowing the breakdown of our naturally most abundant Endocannabinoid, anandamide, thereby resulting in increased levels of anandamide in our system without intoxicating side effects.

High Doses of CBD work better than low doses

Research has suggested that higher doses of CBD isolate are similarly as therapeutic as lower doses of full spectrum CBD extract. The limited clinical research involving CBD and cannabis promises results for dosages as low as 2.5mg. CBD has also shown to potentially have biphasic properties; an excessive amount of CBD could be less effective than a moderate dose.

CBD is fully legal in the United States because hemp is no longer a controlled substance

The legality of CBD is still murky, and the terms of engagement have not yet been defined. Though Congress legalized the production of hemp and hemp-derived CBD nationwide in late 2018, the FDA has yet to develop a regulatory framework for CBD-infused products. This lack of oversight is a loophole for producers to make sub-optimal quality products and make unrealistic health claims. States have taken matters into their own hands, however; some have motioned to fully legalize and regulate CBD-infused food and supplements (as in Colorado) or completely ban over-the-counter CBD products (as in South Dakota). Ivyside maintains that all products we sell are completely legal, produced by trusted suppliers, and verified through third-party testing. This process informs our ability to present accurately labeled, clean, safe, and effective products.